Zomedica Corp. is on the road back to it’s ATH. Easy Hold with a lot of Upside into the New Year Truforma will be released in April 2021!!! February Earning will include Preorders of Truforma Sales Ex CEO of Pfizer is our New CEO He Pushed Out Viagra Back in the Day Ex Vice President of IDEXX is on the Zomedica board also holding 600,000 shares at 16 Cents Board Members, Owners, Works, Banks JP Morgan, Morgan Stanley, Cambridge Are In! Has a lot upswing going into 2021 Even More LT Remember Big Guns can’t go to hard in accumulation it’s not allowed by most institutions and banks. Because it’s under $1 they like stocks that are in the $5 range but as soon as we are in the dollar range which is closer to March a lot PR will be released by their team to skyrocket this to $5+!!! $IDEXX $400+ ZTS MERGER RUMORS QRVO $150+ Zomedica’s Partner in Truforma Make sure your not lending your shares to shorts!!! This about all your investments!!! Check with your Broker!!! Very Important!!! ZOM will be $1+ April 2021 it’s under 25 Cents a Share Always Do Your Own DD Guys!!! The verified Facts: TRUFORMA Commercialization announced for March 2021, domestication & R/S denied, we have forced their hand and are secure Long Term, lawsuit working towards mediation in another 2-11 months, internal launch team complete,70 pending & approved patents, 5 Assays, pending validations and FDA approvals, Qorvo Partnership, Bulk Acoustic Wave (“BAW”) technology, Projected $2.8 billion industry, believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine, latest find is new career openings for (professional services veterinarian, territory diagnostic specialist, and scientist).
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.